Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma. [electronic resource]
Producer: 20100105Description: 5007-15 p. digitalISSN:- 1528-0020
- Animals
- Antibodies, Monoclonal -- chemistry
- Antibodies, Monoclonal, Murine-Derived
- Antibody Affinity
- Antineoplastic Agents -- chemistry
- Apoptosis -- drug effects
- Cell Line, Tumor
- Complementarity Determining Regions -- genetics
- Drug Design
- Drug Resistance, Neoplasm
- Female
- Humans
- Lymphoma, B-Cell -- drug therapy
- Mice
- Mice, SCID
- Point Mutation
- Rituximab
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.